Skip to main content

Table 1 Anti-p62 antibody-positive intra-nuclear inclusions of muscle fibers and non-muscle cells in muscle biopsy

From: Intranuclear inclusions in muscle biopsy can differentiate oculopharyngodistal myopathy and oculopharyngeal muscular dystrophy

 

Muscle fiber (% of all myonuclei)

Blood vessel (% of all nuclei)

Schwann cell/Pericyte (% of all nuclei)

Perineurium (% of all nuclei)

Muscle spindle (% of all nuclei)

OPMD

11.9 ± 1.1 (n = 15)

0 (n = 15)

0 (n = 2)

0 (n  = 2)

0 (n = 1)

OPDM_LRP12

1.0 ± 0.3 (n = 19)

0.7 ± 0.3 (n = 19)

4.0 ± 1.2 (n = 7)

4.1 ± 2.0 (n = 7)

13.2 ± 0.7 (n = 2)

OPDM_GIPC1

0.9 ± 0.4 (n = 6)

0.9 ± 0.5 (n = 6)

18.5 ± 8.8 (n = 2)

8.7 ± 2.2 (n = 2)

18.9 ± 6.9 (n = 2)

OPDM_NOTCH2NLC

1.5 ± 0.3 (n = 7)

8.0 ± 1.8 (n = 7)

13.4 ± 3.4 (n = 5)

15.8 ± 2.8 (n = 5)

16.3 ± 2.0 (n = 2)

NIID

0.2 ± 0.1 (n = 10)

7.2 ± 1.2 (n = 10)

8.0 ± 4.4 (n = 3)

21.8 ± 5.2 (n = 3)

9.1 (n = 1)

IBM

0.6 ± 0.3 (n = 11)

0.5 ± 0.5 (n = 11)

0.6 ± 0.6 (n = 4)

0 (n = 4)

0 (n = 3)

GNE myopathy

0.2 ± 0.1 (n = 11)

0 (n = 10)

0.8 ± 0.8 (n = 6)

0.5 ± 0.7 (n = 6)

5.5 ± 5.5 (n = 2)

IBMPFD

0.9 ± 0.2 (n = 8)

0.2 ± 0.2 (n = 8)

0 (n = 1)

2.6 (n = 1)

0 (n = 1)

DES-related myopathy

0.0 ± 0.0 (n = 7)

0 (n = 7)

0 (n = 3)

0 (n = 3)

NA

Control

0.0 ± 0.0 (n = 6)

0 (n = 6)

0 (n = 2)

0 (n = 2)

0 (n = 1)

  1. Data are shown as Mean ± SEM. OPMD oculopharyngeal muscular dystrophy; OPDM oculopharyngodistal myopathy; NIID neuronal intranuclear inclusion disease; IBM inclusion body myositis; IBMPFD inclusion body myopathy with Paget’s disease of bone and frontotemporal dementia